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Abstract 
Objective 
Self-management of hypertension can reduce and control blood pressure (BP) compared to 
clinic monitoring. However, self-management relies on patients following an algorithm 
which may be variably adhered to. This study reports fidelity of high-risk patients to the self-
management algorithm set by the TASMIN-SR trial.  
Methods  
Patients with hypertension, above target clinic BP and one or more of stroke, diabetes, 
coronary heart disease or chronic kidney disease, were invited to self-monitor following an 
individualised self-titration algorithm. Home BP readings and medication change details 
were submitted monthly for 12 months. Readings downloaded from patients’ electronic 
monitors were compared to written submissions and protocol fidelity was assessed.  
Results  
276 patients were randomised to self-management and 225 (82%) completed the required 
training sessions. Of these, 166 (74%) completed self-management. 11,385/12,707 (89.6%) 
submitted readings were accurate compared to corresponding downloaded monitor 
readings. Mean error rate was 5.2% per patient, which increased with age but not co-
morbidities.   
Patients made 475/683 (69.5%) algorithm recommended medication changes, equating to 
nearly three medication changes per patient. Mean systolic BP for patients who completed 
training and made all recommended changes dropped from 141mmHg (95% CI 138.26-
144.46) to 121mmHg (95% CI 118.30-124.17mmHg) compared to 129mmHg (95% CI 125.27-
136.73mmHg) for patients who made none.  
Conclusion 
Most patients randomised to self-management completed training; however, 36% of these 
had dropped out by 12 months. Self-monitoring was largely undertaken properly and 
accurately recorded. Fidelity with self-management was associated with lower achieved 
systolic BP. Successful implementation of self-management into daily practice requires 
careful training and should be accompanied by monitoring of fidelity.  
 
 Keywords:  
 
Self-management of blood pressure, fidelity to intervention, adherence, persistence,                                                        
training and education 
Introduction 
 
Self-monitored blood pressure (BP) correlates better with cardiovascular outcomes than 
office BP.1 Self-monitoring has become more popular in recent years, as availability of 
monitors and convenience of home measurement has increased,2 and in a UK internet-
based survey, 97% of GPs (general practioners) were found to  have patients who self-
monitor.3 Self-monitoring alone results in small reductions of BP, but co-interventions 
including self-management can lead to greater effect sizes which are longer lasting. The 
TASMINH2 and TASMIN-SR trials have shown the efficacy of self-management of 
hypertension in a hypertensive population and a hypertensive population with co-
morbidities. Previous work has evaluated performance and persistence of self-management 
in the TASMINH2 trial4 showing that, although adherence to recommended medication 
changes reduced over the study, patients made more medication changes than equivalent 
trials which used physician titration.5  
 
The TASMIN-SR trial adapted a self-management intervention used used in a previous trial6 
for implementation in a high-risk, hypertensive patient population. The intervention 
involved patients self-monitoring their BP and making changes to their medication based on 
an agreed titration schedule with their GP. It resulted in greater reductions in systolic BP at 
12 months and an increase in medication use when compared to office management.7 This 
study aimed to evaluate fidelity to the self-management intervention along with the 
accuracy of reporting self-monitored BP in a high-risk, older population with the view to 
explore this as a possible co-intervention to implement in primary care.  
 
 
 
 
 
 
 
 
 
Methods 
 
Population 
Targets and self-management for the control of BP in stroke and at-risk groups (TASMIN-SR) 
was a randomised controlled trial based in primary care. Methods have been described in 
detail elsewhere and are reported here in brief.7, 8  
 
Patients were recruited from 56 UK GP practices. Eligibility criteria were: age ≥35 years, at 
least one high-risk condition (cardiovascular disease, diabetes, stage 3 chronic kidney 
disease, and/or coronary heart disease), and a baseline BP reading ≥130/80mmHg whether 
or not treated. Key exclusions were dementia; BP>180/100mmHg; postural hypotension; 
prescribed more than 3 antihypertensive medications; pregnancy; current specialist 
hypertension care; or acute cardiovascular event in the previous three months. Participants 
were randomised to either self-management (self-monitoring with self-titration) or usual 
care and the primary outcome was office systolic BP after one year (the mean of 2nd/3rd 
readings). Follow-up occurred at six and twelve months. 
 
Self-Monitoring Protocol 
The intervention was developed from the previous TASMINH2 trial.6 Patients were asked to 
self-monitor their BP for the first week of each month of the study and take morning 
measurements using a validated monitor (MicrolifeWatchBP Home).9 The BP target used 
was 130/80mmHg, recommended at the time for high-risk patients by the British 
Hypertension Society10 and Joint British Societies11. The British Hypertension Society 
suggested an adjustment of 10/5mmHg for home readings, so the home BP target in 
TASMIN-SR was 120/75mmHg. Patients were provided with a simple colour coded chart to 
help them interpret their readings: Red (high) >180/100mmHg, Amber (above target) 121-
180/76 – 100mmHg, Green (normal) 100-120/≤75mmHg, Blue (very low) SBP <100mmHg 
(Figure A1 – appendix).  
 
Patients were trained to measure their BP in a seated position with the arm supported on a 
flat surface so the cuff was at the level of the heart. They were asked to take two readings, 
with a minute rest between them, and to colour code the second of the readings using the 
algorithm above. In each week of monitoring any very high or low readings, that persisted 
when a third reading was taken 5 minutes after the second, required the patient to contact 
their surgery for advice. Patients needed to have at least four readings of the same colour in 
order to make a management decision. Four or more raised readings over two consecutive 
months resulted in a recommendation for change in medication. Four or more normal 
readings simply required the patient to continue monitoring the following month. 
Participants used a paper form to record daily readings and any resulting actions.  
  
Self – Titration 
All patients were given a medication review at baseline. Intervention patients were also 
provided with an individualised three-step self-management plan with each step 
recommending a single medication change (increased dose or additional medication), along 
with any required blood tests or other investigations. Medication choices remained at the 
discretion of the GP. An example titration plan is available in the supplementary content 
(Figure A2 – appendix). When a change was required, the patient indicated which step it 
was on their BP measurement form and sent it in to the practice. The practice then issued 
the prescription for the patient to collect as usual. Three medication changes covered the 
patient for a minimum of eight months and they returned to the GP if further medication 
changes were required.  
 
Training  
Patients randomised to self-management were offered two training sessions: both lasted 
approximately an hour with the possibility of a third session if this was required. The first 
session included the requirements of the study, knowing who to contact in case of queries 
or emergencies and learning how to follow the self-monitoring protocol. The second session 
involved explanation of how to colour code the week and when to implement a medication 
change. Patients were assessed to ensure they were capable of self-management. This 
included demonstrating correct use of the BP monitor, recording results, correct application 
of the colour coding system and good knowledge and application of required actions and 
medication changes. Patients were classed as competent if they showed no problems or 
minimal errors they could correct with prompting. Those unable to reliably measure, record 
or colour code BP readings were invited to a third training session. Those assessed as 
competent to self-monitor but not to self-manage were able to continue in the study simply 
monitoring. Those unable to self-monitor were withdrawn from the intervention and 
returned to usual care (though for the purposes of the trial were analysed on an intention-
to-treat basis). 
 
Outcome data 
Patients sent a paper copy of their readings each month to the research team, providing a 
full record of BP readings they had recorded over 12 months. If patients initiated a 
medication change, they sent back a form to the research team. Patients were asked to 
bring their monitor to follow-up clinics when BP data were downloaded to provide a record 
of all readings taken. Patients were not made aware of this until the 6 month follow-up. The 
Microlife Home BP monitor has a memory capacity of 250 readings which enabled the full 
12 months of data to be collected during the two follow up visits.  
 
Analysis 
This was a post-hoc analysis of the TASMIN-SR trial data. Analyses were performed using 
Stata 14 (Stata-Corp). Electronic BP readings were compared to the paper records from 
patients and scores compiled on accuracy of reporting, how well patients followed the 
protocol and whether they interpreted readings correctly. Student t-test was used to 
compare subgroups on age (under 65 vs over 65 years), months 1-5 of the study vs months 
6-11 and one vs multiple co-morbidities.12  A Wilcoxon-type test for trend13 was used to 
explore the association between proportion of recommended medication changes made to 
the systolic BP at 12 month follow-up.  
 
Ethical Approval 
Ethical approval for the original TASMIN-SR trial was obtained from the North West Greater 
Manchester East ethics committee (reference: 10/H1013/60) and site-specific research 
approval was obtained from the relevant primary care organizations. 
 
  
Results 
Completion of Training  
Of 276 patients randomised to the intervention, 225 (82%) completed both training sessions 
(Figure 1). Fifty-one patients did not complete the training: fifty did so of their own choice: 
one was withdrawn from training and the trial on advice from his/her GP (Figure 1). 
 
Persistence with self-management throughout the study 
At the start of the study 15/225 (7%) patients were unable to self-manage therefore 
switched to self-monitoring alone (Figure 1). Four of these patients had no self-titration plan 
provided by their GP. The remaining 11 (73%) were either unable or unwilling to self-titrate. 
Over the study period a further nine patients switched to self-monitoring alone: six were 
advised not to self-manage by their GP, and three chose not to self-manage. Eight of the 
fifteen patients who were self-monitoring alone stopped monitoring completely. By twelve 
months, 182/225 (81%) patients who had completed training, continued to self-manage 
(166, 74%) or had switched to self-monitoring alone (16, 7%).  
 
Persistence with self-monitoring/management of blood pressure and medication use 
Of the 43 (19.1%) participants who stopped self-monitoring completely, 38 (16.9%) 
attended final follow-up. No significant differences existed in baseline characteristics 
between patients that persisted with self-monitoring (n=182) versus those that did not 
(n=38) (Table A1 - Appendix). Primary outcome of the trial was mean of 2nd/3rd systolic BP 
readings at 12 months. Mean office systolic BP was significantly lower for patients who self-
monitored/self-managed, when compared with those patients who did not ((126mmHg 
(95% CI 123-128) vs 141mmHg (95% CI 134-147)). Patients who completed self-management 
(n = 166) were prescribed more medication (defined daily dose) at 12 months compared to 
the patients (n = 38) that stopped self-monitoring completely (3.6 (95% CI 3.3 -3.9) vs 2.3 
(95% CI 1.7-2.9) (Table A1 - Appendix).  
 
 
 
 
 
Self-Monitoring Protocol 
For one intervention patient no monitor readings were available meaning that the following 
analyses comprise 181 participants (99%) who continued to self-monitor or self-manage 
throughout the study. 
 
Readings downloaded from the monitor showed that 1861/1936 (96%) of monitored 
months in the study period included sufficient readings for a management decision to be 
made. In nearly all cases 12,836/12,929 (99%), based on the monitor clock from the 
downloaded readings, at least one minute was allowed between consecutive readings. 13% 
of the monitoring months were in the target range. The proportion of months in target was 
significantly higher in the second six months of the study (6.6% vs 19.2%, p<0.001). 
 
Response to very high and low readings 
Participants took two readings on each occasion and acted on the second. In the case of 
very high second readings (≥181mmHg systolic or ≥101mmHg diastolic), patients were 
instructed to take a third reading, and followed these instructions 83% of the time. Very 
high readings (ranged here from 181–209mmHg systolic or 101–148mmHg diastolic) 
occurred in 3% of study months requiring urgent GP follow-up for 32 patients. Details of 
appointments from practice medical records evidenced that 53% of patients followed up a 
very high reading with their GP practice. 9/19 (47%) patients with only one very high reading 
followed this up with their GP. This was slightly higher for patients with more than one very 
high reading, with 8/13 (62%) patients contacting their GP at least once. 
 
In the case of very low second readings (i.e. systolic <100mmHg, 1% of study months), 
patients took a third reading 68% of the time. This affected 19 patients of whom 7 (37%) 
followed up with a health professional according to their medical records. Seven patients 
reported more than one very low reading, but were no more likely to seek medical advice 
than patients with only one.  
 
 
 
 
Accuracy of Reporting BP Readings 
 
Out of 13093 readings taken during the study from whom data were available, 12707 
(97.1%) downloaded readings could be matched to a paper record by date. There were 
224/13093 (1.7%) readings present in the monitor memory not reported on paper and 
162/13093 (1.2%) readings reported on paper which were not present in the monitor 
memory. Of the 12707 readings matched by date, 11385/12707 (89.6%) readings matched 
exactly for blood pressure level between paper and monitor memory. A further 373 /12707 
(2.9%) were within 5mmHg of readings downloaded from the monitor memory. In 
461/12707 (3.6%) cases patients took three readings and selected two to report. The 
remaining 493/12707 (3.9%) readings were misreported and the reading did not correspond 
with any monitor reading taken the same date. Misreporting and selective reporting led to 
subsequent management being potentially affected in 40/1828 (2.2%) months. In 4/40 
(10%) of these months, readings were close to a threshold, where a difference of 1 or 
2mmHg between paper and downloaded readings, changed the outcome of a given months 
readings. These discrepancies made very little difference to the overall mean BP between 
the downloaded and reported readings ((-0.26mmHg systolic (95% CI -0.30-0.22) (-
0.17mmHg diastolic (95% CI -0.21-0.14)). 5223/5850 (89.3%) BP readings matched exactly in 
months 1-5, compared to 6162/6857 (89.9%) in months 6 – 12 following the 6 month follow 
up when patients would be made aware of the study nurse downloading readings from the 
monitor memory.  
 
Overall the mean error rate per patient was 5.2%. This was not affected by the number of 
co-morbidities, but patients over 65 years had a higher error rate compared to those below, 
6.1% (95% CI 4.8-7.4) vs 3.1% (95% CI 2.1-4.0) p<0.05. A small proportion, 9/181 (5%) 
patients, reported their BP with ≤80% accuracy. 
 
Self-Titration 
Based on the downloaded BP readings for patients who completed self-management 
(n=166), 683 medication changes were expected. This equates to treatment intensification 
for 40% of all monitoring months and just over four recommended medication changes per 
patient. Patients made two-thirds of these medication changes (475/683, 69.5%), equating 
to nearly three changes per patient. Implemented medication changes were accompanied 
by health professional contact in around a third of cases (171/475, 36%).  
 
The proportion of medication changes implemented was associated with achieved mean 
systolic BP at 12 months, ranging from 129mmHg (no recommended changes made) to 
121mmHg (all changes made) (Table 1). A test for trend13 showed that the drop in BP was 
significant according to the proportion of medication changes made (p<0.05).  
 
Of the 208 (30.5%) recommended medication changes not carried out, 106 (51%) reported a 
reason and 102 (49%) did not (Figure 2). The decision not to make a medication change was 
guided by a health professional about a third of the time and made exclusively by the 
patient the remaining two-thirds. Reasons given included side effects and borderline 
readings (Figure 2).  
 
Discussion 
People in a high-risk, older, hypertensive population can be successfully trained to self-
monitor their BP and make appropriate management decisions concerning self-titration. 
The majority of trained patients completed self-management over an extended period and 
followed a structured management decision resulting in significantly lower BP than the 
control group and patients randomised to self-management who withdrew. Monitoring was 
carried out to a high standard and almost all monitoring months included sufficient readings 
to make a management decision.  
 
For self-management to be a reality, safety is a prime concern. In the case of very high 
readings, patients took an additional reading in the majority of cases and there was 
evidence that almost half were followed up by a health professional. Of those that did not 
contact their GP immediately, BP subsequently stabilised or they contacted their GP the 
following month. Performance following very low readings was less faithful to the protocol 
and many patients did not follow-up with additional readings or GP contact. However, 
reported symptomatic postural hypotension was rare and led to GP contact in all cases. 
Arguably, as most people were asymptomatic such additional contact could probably be 
optional in practice.  
Patients reported their BP reasonably accurately with a close match between downloaded 
and reported readings. Misreporting or selective reporting changed the outcome for a very 
small percentage of months and overall mean BP between the downloaded and reported 
readings was almost identical. Patients over 65 years old had a significantly higher error 
rate, but the absolute error values were low suggesting it would be unlikely to affect 
outcome. Furthermore, the effect size of self-management in the trial was at least as great 
in people over the age of 65 as in people below that age. Patients who made all their 
recommended medication changes had significantly lower mean systolic BP at the final 
follow-up than those who made none. However patients who made no changes still had a 
lower mean BP at 12 months compared to the usual care patients. Three patients had no 
recommended medication changes and a mean systolic of 119.8mmHg at 12 months 
suggesting that they had a white coat effect at baseline, which attenuated over time.  
 
Comparison with other literature 
One other trial has evaluated large scale self-management and included 526 patients with 
largely uncomplicated but poorly controlled hypertension.6 Higher proportions of patients in 
that trial completed self-management training (92% vs 82%) and subsequently completed 
the trial continuing to self-manage than did here (77% vs 66%).6 Patients in the current trial 
were older, with a higher number of morbidities, so it is perhaps expected that self-
management may have been more challenging. However, once trained, very similar 
proportions persisted with self-management (79% vs 78%).  
 
Interestingly, the overall BP reduction in TASMIN-SR was greater than that in TASMINH2 
(9.2mmHg vs 5.4mmHg) despite lower baseline BP (144mmHg vs 155mmHg). This might 
reflect both a lower target (130/85mmHg vs 140/90mmHg) leading to more medication 
change recommendations per person (4.1 (683/166) vs 2.6 (483/188)) and a higher 
acceptance of medication changes in the former: 69% (475/683) vs 55% (268/483). Similarly 
a greater proportion of active patients in the current study made a medication change 
compared to TASMINH2 (140 (84%) vs 131 (70%)).6 This was achieved in both trials with 
very little in the way of adverse effects reported compared to control.6, 7 
 
Others have found evidence of reporting bias in situations where the patient records their 
BP on paper and takes it into the doctor.14 The level of reporting accuracy here may be due 
in part to the Hawthorne Effect, where a research study influences the behaviour of the 
patient.15,16 In cases where readings have been compared in routine clinical practice, 
without the patient being aware of the memory capacity of the monitor, the comparison 
between readings on the monitor and those recorded on paper appears to be less close.17, 18 
However here there was very little difference in the accuracy of reported readings whether 
patients were aware that readings would be downloaded or not. 
 
Training given to patients at baseline is likely to have affected fidelity to the protocol. A 
recent Canadian study highlighted poor reporting and persistence with self-monitoring 
procedures following the implementation of a passive educational strategy four years 
earlier.19 Health professionals were encouraged to explain home BP monitoring to patients 
and educational materials were distributed in primary care centres. In contrast the training 
reported in the current study was standardised and took place on at least two sessions with 
structured assessments to ensure patients understood the procedures and algorithm to 
follow at home.  
 
Two-thirds of the algorithm derived medication changes were implemented in the TASMIN-
SR trial which is higher than the HINTS trial (45%) in Canada which used physician titration.5 
In that trial, the main reason for not implementing medication intensification appeared to 
be borderline readings.5 Borderline or improving readings were also a factor in patients 
choosing not to initiate a medication change here (Figure 2) and qualitative work showed 
that this was also a finding for TASMINH2 patients.20  
 
Side effects or adverse reactions were not different overall between intervention and 
control groups in the trial.7 However, they were cited by patients as a reason not to initiate 
a medication change. Unfortunately, we were not able to relate adherence to the type of 
medication change. Adverse events leading to discontinuations of treatment were reviewed 
in a recent meta-analysis which found similar rates of adverse events, leading to 
discontinuation of treatment, between antihypertensive drug classes, with the exception of 
angiotensin receptor blockers which showed a significantly lower risk. However 
discontinuation of treatment due to adverse events was also related to the number of 
cardiovascular prevention drugs which is relevant in any intervention resulting in up-
titration of medication.21  
 
In the TASMIN-SR trial it appears that even patients who made no recommended 
medication changes had lower BP following the intervention, (Table 3). This may be because 
self-monitoring increases adherence to medication.22 Decisions not to implement treatment 
intensification may have been countered by an increased willingness to take existing 
medications, possibly because the self-monitoring schedule acted as a prompt for patients 
to take their medications.  
 
Strengths and Limitations 
TASMIN-SR was the first trial adequately powered to show the feasibility and efficacy of a 
self-management intervention for an older, at-risk population.7 Patients showed willingness 
to complete the training, but only 65% remained self-monitoring at 12 months. Although a 
more intensive measurement schedule for self-monitoring is now recommended in the 
guidelines23 given the challenges in getting patients to continue self-managing one might 
argue that our schedule is more acceptable for patients.24 The prognostic significance of 
morning BP has also been highlighted, consistent with our approach to base management 
decisions on morning BP readings.25 Of patients who completed training, 73% remained self-
managing at 12 months and 9% opted to self-monitor only during the trial, therefore it is 
unlikely that all patients would be able to self-titrate. However, this appears to be related to 
individual choice and not age or health condition. Similarly age or co-morbidities did not 
seem to influence whether patients would complete the training and persist with the 
intervention but these results were underpowered to draw any firm conclusions. 
 
Patients did not always follow-up very low or very high readings. This may be because they 
felt they had to wait for an appointment to see the study GP rather than contacting the 
surgery as an emergency or they waited to discuss it with their own GP. There was some 
misreporting and selective reporting, however, given it was a very small number it could 
equally have been due to a transcription error. This aspect of the intervention may require 
further refinement to ensure patient safety and minimise selective reporting. Patients above 
65 years were not quite as accurate in reporting their readings suggesting this group needs 
more supportive and intensive training which may be challenging to implement in general 
practice. However, the error rate for these patients was still fairly low showing that older 
patients are competent to monitor at home and understand what to do with the readings. It 
should be noted that the Hawthorn effect15 may have caused patients to be more adherent 
to the intervention simply by being part of the study. A high proportion of these patients 
had professional or skilled occupations and few came from areas of low deprivation (Table 
A1 – Appendix), therefore the generalisability of these results to the wider population may 
be limited. 
 
BP control significantly increased over the 12 months of the trial as patients made more 
medication changes. However analysis of home readings showed only 19.2% of months 
were considered in target range at 12 months. The BP targets in the TASMIN-SR trial were 
lower than the current guidelines suggest and more in line with the tight BP targets of the 
recent SPRINT trial.26 This was challenging in an older, sicker population as any changes in 
medication had to be weighed up by the patient against the number of medications they 
were already prescribed and any side effects they experienced.  The results of the SPRINT 
trial have inspired lower BP targets in the Canadian guidelines27 for selected patients at high 
cardiovascular risk but the reality of achieving these targets in patients is uncertain. Self-
management provides a means for patients to optimise their individual BP control by 
balancing their medications against achieving their BP target.  
 
The growing popularity of telemonitoring and smart phones28-30 is likely to have a role in the 
future of home BP monitoring. Our protocol could easily adapt to these technologies. 
However, the patient training is intensive and work is needed in order to effectively 
implement it into primary care.  
 
Conclusion 
 
This study has shown the feasibility of a self-management protocol in an older, at-risk 
patient group, with a high proportion following the protocol reasonably closely and 
reporting their readings accurately. Patients were willing to make changes to intensify their 
treatment two-thirds of the time but a third of treatment changes involved consultation 
with the GP beforehand, showing communication between the health professional and 
patient remains essential even for self-management. Treatment intensification resulting 
from self-management resulted in similar achieved BP to the intensive group in SPRINT26 
(Table A1 – Appendix).  
 
Self-monitoring features significantly in best practice guidelines in the UK23 and 
internationally27, 31 and is becoming a routine part of hypertension management in primary 
care.32 However there are inconsistencies in how it is measured and how patients report 
readings to GPs. A recent individual patient data analysis on self-monitoring of hypertension 
highlighted the importance of professional support in achieving reductions in BP.33 The self-
management intervention here features a structured training programme and a clear, 
specific algorithm for patients to follow. Further implementation work is needed to adapt 
these trial materials and the intervention training for delivery by practice nurses or other 
general practice staff. Self-management of hypertension is effective and feasible. Standardising 
this intervention on a wider scale with delivery by clinical staff not researchers will allow the 
full potential of self-monitoring and self-management to be available to the wider 
hypertensive population.    
 
Acknowledgements 
Roger Holder, Emeritus Head of Statistics in Primary Care in (University of Birmingham), who 
was the original trial statistician before handing over to Dr Haque. Nicki Spillman and Beryl 
Caswell for their input into the Steering Group as Voluntary Lay Representatives. The 
Primary Care Research Network Central England (specifically Mrs Ros Salter, Ms Jenny 
Stevens, Ms Jenny Titley, Prof Jeremy Dale, Ms Sue Elwell, and Dr Mark Porcheret) and 
Primary Care Research Network East of England (specifically Ms Camilla Croucher, and Dr 
Jonathan Graffy), none of whom received compensation. The authors would like to 
acknowledge their contribution to this work. We would like to acknowledge the input of 
participating patients, practices, and the NIHR Clinical Research network, without whom this 
research would not be possible. The views expressed are those of the authors and not 
necessarily those of the NHS, the NIHR or the Department of Health. 
 References 
[1] Ward, A. M., Takahashi, O., Stevens, R., and Heneghan, C. (2012) Home measurement of blood 
pressure and cardiovascular disease: systematic review and meta-analysis of prospective 
studies, Journal of hypertension 30, 449-456. 
[2] Baral-Grant, S., Haque, M. S., Nouwen, A., Greenfield, S. M., and McManus, R. J. (2012) Self-
Monitoring of Blood Pressure in Hypertension: A UK Primary Care Survey, Int J Hypertens 
2012, 582068. 
[3] Fletcher, B. R., Hinton, L., Bray, E. P., Hayen, A., Hobbs, F. R., Mant, J., Potter, J. F., and McManus, 
R. J. (2016) Self-monitoring blood pressure in patients with hypertension: an internet-based 
survey of UK GPs, The British journal of general practice : the journal of the Royal College of 
General Practitioners 66, e831-e837. 
[4] Bray, E. P., Jones, M. I., Banting, M., Greenfield, S., Hobbs, F. D., Little, P., Williams, B., and 
McManus, R. J. (2015) Performance and persistence of a blood pressure self-management 
intervention: telemonitoring and self-management in hypertension (TASMINH2) trial, 
Journal of human hypertension 29, 436-441. 
[5] Crowley, M. J., Smith, V. A., Olsen, M. K., Danus, S., Oddone, E. Z., Bosworth, H. B., and Powers, B. 
J. (2011) Treatment intensification in a hypertension telemanagement trial: clinical inertia or 
good clinical judgment?, Hypertension 58, 552-558. 
[6] McManus, R. J., Mant, J., Bray, E. P., Holder, R., Jones, M. I., Greenfield, S., Kaambwa, B., Banting, 
M., Bryan, S., Little, P., Williams, B., and Hobbs, F. D. (2010) Telemonitoring and self-
management in the control of hypertension (TASMINH2): a randomised controlled trial, 
Lancet 376, 163-172. 
[7] McManus, R. J., Mant, J., Haque, M. S., Bray, E. P., Bryan, S., Greenfield, S. M., Jones, M. I., 
Jowett, S., Little, P., Penaloza, C., Schwartz, C., Shackleford, H., Shovelton, C., Varghese, J., 
Williams, B., and Hobbs, F. D. (2014) Effect of self-monitoring and medication self-titration 
on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the 
TASMIN-SR randomized clinical trial, JAMA : the journal of the American Medical Association 
312, 799-808. 
[8] O'Brien, C., Bray, E. P., Bryan, S., Greenfield, S. M., Haque, M. S., Hobbs, F. D., Jones, M. I., Jowett, 
S., Kaambwa, B., Little, P., Mant, J., Penaloza, C., Schwartz, C., Shackleford, H., Varghese, J., 
Williams, B., and McManus, R. J. (2013) Targets and self-management for the control of 
blood pressure in stroke and at risk groups (TASMIN-SR): protocol for a randomised 
controlled trial, BMC cardiovascular disorders 13, 21. 
[9] Stergiou, G. S., Giovas, P. P., Gkinos, C. P., and Patouras, J. D. (2007) Validation of the Microlife 
WatchBP Home device for self home blood pressure measurement according to the 
International Protocol, Blood pressure monitoring 12, 185-188. 
[10] Williams, B., Poulter, N. R., Brown, M. J., Davis, M., McInnes, G. T., Potter, J. F., Sever, P. S., and 
Thom, S. (2004) Guidelines for management of hypertension: report of the fourth working 
party of the British Hypertension Society, 2004-BHS IV, J Hum.Hypertens 18, 139-185. 
[11] British Cardiac, S., British Hypertension, S., Diabetes, U. K., Heart, U. K., Primary Care 
Cardiovascular, S., and Stroke, A. (2005) JBS 2: Joint British Societies' guidelines on 
prevention of cardiovascular disease in clinical practice, Heart 91 Suppl 5, v1-52. 
[12] Altman, D. G. (1991) Practical statistics for medical research, Vol. First, Chapman & Hall, London. 
[13] Cuzick, J. (1985) A Wilcoxon-type test for trend, Statistics in medicine 4, 87-90. 
[14] Myers, M. G., and Stergiou, G. S. (2014) Reporting bias: Achilles' heel of home blood pressure 
monitoring, Journal of the American Society of Hypertension : JASH 8, 350-357. 
[15] Sedgwick, P. (2012) The Hawthorne effect, Bmj 344, d8262. 
[16] Bachmann, L. M., Steurer, J., Holm, D., and Vetter, W. (2002) To what extent can we trust home 
blood pressure measurement? A randomized, controlled trial, Journal of clinical 
hypertension 4, 405-407, 412. 
[17] Myers, M. G. (2001) Reporting bias in self-measurement of blood pressure, Blood pressure 
monitoring 6, 181-183. 
[18] Mengden, T., Hernandez Medina, R. M., Beltran, B., Alvarez, E., Kraft, K., and Vetter, H. (1998) 
Reliability of reporting self-measured blood pressure values by hypertensive patients, 
American journal of hypertension 11, 1413-1417. 
[19] Milot, J. P., Birnbaum, L., Larochelle, P., Wistaff, R., Laskine, M., Van Nguyen, P., and Lamarre-
Cliche, M. (2015) Unreliability of home blood pressure measurement and the effect of a 
patient-oriented intervention, The Canadian journal of cardiology 31, 658-663. 
[20] Jones, M. I., Greenfield, S. M., Bray, E. P., Baral-Grant, S., Hobbs, F. D., Holder, R., Little, P., 
Mant, J., Virdee, S. K., Williams, B., and McManus, R. J. (2012) Patients' experiences of self-
monitoring blood pressure and self-titration of medication: the TASMINH2 trial qualitative 
study, Br.J.Gen.Pract. 62, e135-e142. 
[21] Thomopoulos, C., Parati, G., and Zanchetti, A. (2016) Effects of blood-pressure-lowering 
treatment in hypertension: 9. Discontinuations for adverse events attributed to different 
classes of antihypertensive drugs: meta-analyses of randomized trials, Journal of 
hypertension 34, 1921-1932. 
[22] Fletcher, B. R., Hartmann-Boyce, J., Hinton, L., and McManus, R. J. (2015) The Effect of Self-
Monitoring of Blood Pressure on Medication Adherence and Lifestyle Factors: A Systematic 
Review and Meta-Analysis, American journal of hypertension 28, 1209-1221. 
[23] NICE. (2011) Hypertension: Clinical Management of Primary Hypertension in Adults, London. 
[24] Grant, S., Hodgkinson, J. A., Milner, S. L., Martin, U., Tompson, A., Hobbs, F. R., Mant, J., 
McManus, R. J., and Greenfield, S. M. (2016) Patients' and clinicians' views on the optimum 
schedules for self-monitoring of blood pressure: a qualitative focus group and interview 
study, The British journal of general practice : the journal of the Royal College of General 
Practitioners. 
[25] Sheppard, J. P., Hodgkinson, J., Riley, R., Martin, U., Bayliss, S., and McManus, R. J. (2015) 
Prognostic significance of the morning blood pressure surge in clinical practice: a systematic 
review, American journal of hypertension 28, 30-41. 
[26] Sprint Research Group, Wright, J. T., Jr., Williamson, J. D., Whelton, P. K., Snyder, J. K., Sink, K. 
M., Rocco, M. V., Reboussin, D. M., Rahman, M., Oparil, S., Lewis, C. E., Kimmel, P. L., 
Johnson, K. C., Goff, D. C., Jr., Fine, L. J., Cutler, J. A., Cushman, W. C., Cheung, A. K., and 
Ambrosius, W. T. (2015) A Randomized Trial of Intensive versus Standard Blood-Pressure 
Control, The New England journal of medicine 373, 2103-2116. 
[27] Leung, A. A., Nerenberg, K., Daskalopoulou, S. S., McBrien, K., Zarnke, K. B., Dasgupta, K., 
Cloutier, L., Gelfer, M., Lamarre-Cliche, M., Milot, A., Bolli, P., Tremblay, G., McLean, D., 
Tobe, S. W., Ruzicka, M., Burns, K. D., Vallee, M., Prasad, G. V., Lebel, M., Feldman, R. D., 
Selby, P., Pipe, A., Schiffrin, E. L., McFarlane, P. A., Oh, P., Hegele, R. A., Khara, M., Wilson, T. 
W., Penner, S. B., Burgess, E., Herman, R. J., Bacon, S. L., Rabkin, S. W., Gilbert, R. E., 
Campbell, T. S., Grover, S., Honos, G., Lindsay, P., Hill, M. D., Coutts, S. B., Gubitz, G., 
Campbell, N. R., Moe, G. W., Howlett, J. G., Boulanger, J. M., Prebtani, A., Larochelle, P., 
Leiter, L. A., Jones, C., Ogilvie, R. I., Woo, V., Kaczorowski, J., Trudeau, L., Petrella, R. J., 
Hiremath, S., Drouin, D., Lavoie, K. L., Hamet, P., Fodor, G., Gregoire, J. C., Lewanczuk, R., 
Dresser, G. K., Sharma, M., Reid, D., Lear, S. A., Moullec, G., Gupta, M., Magee, L. A., Logan, 
A. G., Harris, K. C., Dionne, J., Fournier, A., Benoit, G., Feber, J., Poirier, L., Padwal, R. S., Rabi, 
D. M., and Force, C. G. T. (2016) Hypertension Canada's 2016 Canadian Hypertension 
Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of 
Risk, Prevention, and Treatment of Hypertension, The Canadian journal of cardiology 32, 
569-588. 
[28] Purcell, R., McInnes, S., and Halcomb, E. J. (2014) Telemonitoring can assist in managing 
cardiovascular disease in primary care: a systematic review of systematic reviews, BMC 
family practice 15, 43. 
[29] de Jongh, T., Gurol-Urganci, I., Vodopivec-Jamsek, V., Car, J., and Atun, R. (2012) Mobile phone 
messaging for facilitating self-management of long-term illnesses, The Cochrane database of 
systematic reviews 12, CD007459. 
[30] Cottrell, E., Chambers, R., and O'Connell, P. (2012) Using simple telehealth in primary care to 
reduce blood pressure: a service evaluation, BMJ open 2. 
[31] Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Bohm, M., Christiaens, T., Cifkova, 
R., De Backer, G., Dominiczak, A., Galderisi, M., Grobbee, D. E., Jaarsma, T., Kirchhof, P., 
Kjeldsen, S. E., Laurent, S., Manolis, A. J., Nilsson, P. M., Ruilope, L. M., Schmieder, R. E., 
Sirnes, P. A., Sleight, P., Viigimaa, M., Waeber, B., Zannad, F., Burnier, M., Ambrosioni, E., 
Caufield, M., Coca, A., Olsen, M. H., Tsioufis, C., van de Borne, P., Zamorano, J. L., 
Achenbach, S., Baumgartner, H., Bax, J. J., Bueno, H., Dean, V., Deaton, C., Erol, C., Ferrari, R., 
Hasdai, D., Hoes, A. W., Knuuti, J., Kolh, P., Lancellotti, P., Linhart, A., Nihoyannopoulos, P., 
Piepoli, M. F., Ponikowski, P., Tamargo, J. L., Tendera, M., Torbicki, A., Wijns, W., Windecker, 
S., Clement, D. L., Gillebert, T. C., Rosei, E. A., Anker, S. D., Bauersachs, J., Hitij, J. B., 
Caulfield, M., De Buyzere, M., De Geest, S., Derumeaux, G. A., Erdine, S., Farsang, C., Funck-
Brentano, C., Gerc, V., Germano, G., Gielen, S., Haller, H., Jordan, J., Kahan, T., Komajda, M., 
Lovic, D., Mahrholdt, H., Ostergren, J., Parati, G., Perk, J., Polonia, J., Popescu, B. A., Reiner, 
Z., Ryden, L., Sirenko, Y., Stanton, A., Struijker-Boudier, H., Vlachopoulos, C., Volpe, M., and 
Wood, D. A. (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: 
The Task Force for the management of arterial hypertension of the European Society of 
Hypertension (ESH) and of the European Society of Cardiology (ESC), European heart journal 
34, 2159-2219. 
[32] McManus, R. J., Wood, S., Bray, E. P., Glasziou, P., Hayen, A., Heneghan, C., Mant, J., Padfield, P., 
Potter, J. F., and Hobbs, F. D. (2014) Self-monitoring in hypertension: a web-based survey of 
primary care physicians, Journal of human hypertension 28, 123-127. 
[33] Tucker, K. L., Sheppard, J. P., Stevens, R., Bosworth, H. B., Bove, A., Bray, E. P., Earle, K., George, 
J., Godwin, M., Green, B. B., Hebert, P., Hobbs, F. D. R., Kantola, I., Kerry, S. M., Leiva, A., 
Magid, D. J., Mant, J., Margolis, K. L., McKinstry, B., McLaughlin, M. A., Omboni, S., 
Ogedegbe, O., Parati, G., Qamar, N., Tabaei, B. P., Varis, J., Verberk, W. J., Wakefield, B. J., 
and McManus, R. J. (2017) Self-monitoring of blood pressure in hypertension: A systematic 
review and individual patient data meta-analysis, PLoS medicine 14, e1002389. 
Supplemental Digital Content 1. doc 
